Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Polypharmakos Logo
Polypharmakos Growth Score
81
CB Rank
991531
Heat Score
65
Polypharmakos's mission is to discover and develop new antimicrobials from plants, fungi.
Founded
obfuscation
PrivateSeries A Cambridge, Cambridgeshire, United Kingdom1-10 www.polypharmakos.com
Biotechnology
Overview

Polypharmakos
Growth Score
81
Heat Score
65

Growth Score81
-5 pts
in past quarter
Heat Score 65
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Polypharmakos

CB Rank
991531
Polypharmakos's mission is to discover and develop new antimicrobials from plants, fungi.
Founded
obfuscation
PrivateSeries A Cambridge, Cambridgeshire, United Kingdom1-10 www.polypharmakos.com
Biotechnology

Funding Rounds

Series A
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
Polypharmakos's mission is to discover and develop new antimicrobials from plants, fungi and other natural product sources to address the emerging global antimicrobial resistance (AMR) crisis.
Phone Number (783)180-0683
Contact Email info@polypharmakos.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Natural Extract Discovery Platform
A platform that uses AI and ethnobotanical knowledge to identify therapeutic compounds from plants and fungi for nutraceutical, functional food, and pharmaceutical applications.
Inflammaging Research and Product Development
Research and development focused on natural extracts that influence inflammation related to aging, aiming to create products for managing age-related inflammatory conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A
obfuscation
Series A - Polypharmakos Logo
Series A - Polypharmakos
2
obfuscation
Parkwalk AdvisorsSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

IT Spend

$217.1KThis year, Polypharmakos is projected to spend $217.1K on IT, according to Aberdeen.

Active Website Tech Count

3Polypharmakos is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Polypharmakos's headquarters? Polypharmakos is located in Cambridge, Cambridgeshire, United Kingdom.Who invested in Polypharmakos? Polypharmakos has 2 investors including University of Cambridge Enterprise and  Parkwalk Advisors.When was the last funding round for Polypharmakos? Polypharmakos closed its last funding round on
obfuscation
from a Series A round.Who are Polypharmakos's competitors? Alternatives and possible competitors to Polypharmakos may include Ginkgo Bioworks, Arzeda, and  one.bio.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|